Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 3646 AL 3660

Membrane trafficking in neuronal maintenance and degeneration

Wang D, Chan CC, Cherry S, Hiesinger PR.

Cell Mol Life Sci. 2013 Aug;70(16):2919-34. doi: 10.1007/s00018-012-1201-4. Epub 2012 Nov 8.

Parkinson's disease and osteoporosis

van den Bos F, Speelman AD, Samson M, Munneke M, Bloem BR, Verhaar HJ.

Age Ageing. 2013 Mar;42(2):156-62. doi: 10.1093/ageing/afs161. Epub 2012 Nov 6.

Validation of robust tools to measure sialorrhea in amyotrophic lateral sclerosis: a study in a large French cohort

Abdelnour-Mallet M, Tezenas Du Montcel S, Cazzolli PA, Assouline A, Pointon C, Leveque N, Dominique H, Elmazria H, Rothmayer M, Lenglet T, Bruneteau G, le Forestier N, Delanian S, Gonzalez-Bermejo J, Salachas F, Brooks BR, Pradat PF.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):302-7. doi: 10.3109/21678421.2012.735238. Epub 2012 Oct 24.

Intranasal treatment of central nervous system dysfunction in humans

Chapman CD, Frey WH 2nd, Craft S, Danielyan L, Hallschmid M, Schiöth HB, Benedict C.

Pharm Res. 2013 Oct;30(10):2475-84. doi: 10.1007/s11095-012-0915-1. Epub 2012 Nov 8.

Effect of externally cued training on dynamic stability control during the sit-to-stand task in people with Parkinson disease

Bhatt T, Yang F, Mak MK, Hui-Chan CW, Pai YC.

Phys Ther. 2013 Apr;93(4):492-503. doi: 10.2522/ptj.20100423. Epub 2012 Nov 8.

[Parkinsonian disorders: from clinical manifestations to diagnostic classification]

Bourdain F, Tir M, Trocello JM.

Rev Med Interne. 2013 Sep;34(9):528-37. doi: 10.1016/j.revmed.2012.09.017. Epub 2012 Nov 9.

Motor deficits associated with changes in β-amyloid in Parkinson's disease

Halliday GM.

J Neurol Neurosurg Psychiatry. 2013 May;84(5):475-6. doi: 10.1136/jnnp-2012-304177. Epub 2012 Nov 9.

Parkinson's disease patients show reduced cortical-subcortical sensorimotor connectivity

Sharman M, Valabregue R, Perlbarg V, Marrakchi-Kacem L, Vidailhet M, Benali H, Brice A, Lehéricy S.

Mov Disord. 2013 Apr;28(4):447-54. doi: 10.1002/mds.25255. Epub 2012 Nov 9.

1-Hz repetitive transcranial magnetic stimulation and diphasic dyskinesia in Parkinson's disease

Filipović SR, Bhatia KP, Rothwell JC.

Mov Disord. 2013 Feb;28(2):245-6. doi: 10.1002/mds.25261. Epub 2012 Nov 9.

Variability in cadence during forced cycling predicts motor improvement in individuals with Parkinson's disease

Ridgel AL, Abdar HM, Alberts JL, Discenzo FM, Loparo KA.

IEEE Trans Neural Syst Rehabil Eng. 2013 May;21(3):481-9. doi: 10.1109/TNSRE.2012.2225448. Epub 2012 Oct 24.

Nocebo as a potential confounding factor in clinical trials for Parkinson's disease treatment: a meta-analysis

Stathis P, Smpiliris M, Konitsiotis S, Mitsikostas DD.

Eur J Neurol. 2013 Mar;20(3):527-533. doi: 10.1111/ene.12014. Epub 2012 Nov 12.

Complex visual hallucinations in a Parkinson patient: don't blame James if it's Charles's fault

Segers K.

Int Psychogeriatr. 2013 Mar;25(3):505-6. doi: 10.1017/S1041610212001913. Epub 2012 Nov 12.

Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects

Mollenhauer B, Trautmann E, Taylor P, Manninger P, Sixel-Döring F, Ebentheuer J, Trenkwalder C, Schlossmacher MG.

Neurosci Lett. 2013 Jan 4;532:44-8. doi: 10.1016/j.neulet.2012.11.004. Epub 2012 Nov 10.

Synucleins: are they two-edged swords?

Surguchov A.

J Neurosci Res. 2013 Feb;91(2):161-6. doi: 10.1002/jnr.23149. Epub 2012 Nov 14.

Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease

Pihlstrøm L, Axelsson G, Bjørnarå KA, Dizdar N, Fardell C, Forsgren L, Holmberg B, Larsen JP, Linder J, Nissbrandt H, Tysnes OB, Ohman E, Dietrichs E, Toft M.

Neurobiol Aging. 2013 Jun;34(6):1708.e7-13. doi: 10.1016/j.neurobiolaging.2012.10.019. Epub 2012 Nov 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias